Common Contracts
10 similar null contracts by Cytori Therapeutics, Inc.
WARRANT TO PURCHASE 92,797 SHARES OF COMMON STOCKCytori Therapeutics, Inc. • August 9th, 2013 • Surgical & medical instruments & apparatus • California
This Warrant is issued pursuant to that certain Loan and Security Agreement, dated as of June 28, 2013, by and among Company, the other entities or persons signatory thereto as loan parties, Oxford Finance LLC, a Delaware limited liability company, as agent and lender, and the other financial institutions signatory thereto from time to time as lenders.
WARRANT TO PURCHASE 162,395 SHARES OF COMMON STOCKCytori Therapeutics, Inc. • August 9th, 2013 • Surgical & medical instruments & apparatus • California
This Warrant is issued pursuant to that certain Loan and Security Agreement, dated as of June 28, 2013, by and among Company, the other entities or persons signatory thereto as loan parties, Oxford Finance LLC, a Delaware limited liability company, as agent and lender, and the other financial institutions signatory thereto from time to time as lenders.
WARRANT TO PURCHASE 185,594 SHARES OF COMMON STOCKCytori Therapeutics, Inc. • August 9th, 2013 • Surgical & medical instruments & apparatus • California
This Warrant is issued pursuant to that certain Loan and Security Agreement, dated as of June 28, 2013, by and among Company, the other entities or persons signatory thereto as loan parties, Oxford Finance LLC, a Delaware limited liability company, as agent and lender, and the other financial institutions signatory thereto from time to time as lenders.
WARRANT TO PURCHASE 115,997 SHARES OF COMMON STOCKCytori Therapeutics, Inc. • August 9th, 2013 • Surgical & medical instruments & apparatus • California
This Warrant is issued pursuant to that certain Loan and Security Agreement, dated as of June 28, 2013, by and among Company, the other entities or persons signatory thereto as loan parties, Oxford Finance LLC, a Delaware limited liability company, as agent and lender, and the other financial institutions signatory thereto from time to time as lenders.
WARRANT TO PURCHASE 39,770 SHARES OF COMMON STOCKCytori Therapeutics, Inc. • August 9th, 2013 • Surgical & medical instruments & apparatus • California
This Warrant is issued pursuant to that certain Loan and Security Agreement, dated as of June 28, 2013, by and among Company, the other entities or persons signatory thereto as loan parties, Oxford Finance LLC, a Delaware limited liability company, as agent and lender, and the other financial institutions signatory thereto from time to time as lenders.
WARRANT TO PURCHASE 20253 SHARES OF COMMON STOCKCytori Therapeutics, Inc. • June 17th, 2010 • Surgical & medical instruments & apparatus • New York
THIS CERTIFIES THAT, for value received, Silicon Valley Bank (“Holder”) is entitled to subscribe for and purchase Twenty Thousand Two Hundred Fifty-Three (20253) shares of fully paid and nonassessable Common Stock of Cytori Therapeutics Inc., a Delaware corporation (the “Company”), at the Warrant Price (as hereinafter defined), subject to the provisions and upon the terms and conditions hereinafter set forth. As used herein, the term “Common Stock” shall mean Company’s presently authorized common stock, $0.001 par value per share, and any stock into which such common stock may hereafter be converted or exchanged and the term “Warrant Shares” shall mean the shares of Common Stock which Holder may acquire pursuant to this Warrant and any other shares of stock into which such shares of Common Stock may hereafter be converted or exchanged.
WARRANT TO PURCHASE 50633 SHARES OF COMMON STOCKCytori Therapeutics, Inc. • June 17th, 2010 • Surgical & medical instruments & apparatus • New York
THIS CERTIFIES THAT, for value received, GE Capital Equity Investments, Inc. (“Holder”) is entitled to subscribe for and purchase Fifty Thousand Six Hundred Thirty-Three (50633) shares of fully paid and nonassessable Common Stock of Cytori Therapeutics Inc., a Delaware corporation (the “Company”), at the Warrant Price (as hereinafter defined), subject to the provisions and upon the terms and conditions hereinafter set forth. As used herein, the term “Common Stock” shall mean Company’s presently authorized common stock, $0.001 par value per share, and any stock into which such common stock may hereafter be converted or exchanged and the term “Warrant Shares” shall mean the shares of Common Stock which Holder may acquire pursuant to this Warrant and any other shares of stock into which such shares of Common Stock may hereafter be converted or exchanged.
ContractCytori Therapeutics, Inc. • June 17th, 2010 • Surgical & medical instruments & apparatus • New York
WARRANT TO PURCHASE 89,074 SHARES OF COMMON STOCKCytori Therapeutics, Inc. • March 6th, 2009 • Surgical & medical instruments & apparatus • California
THIS CERTIFIES THAT, for value received, Silicon Valley Bank (“Holder”) is entitled to subscribe for and purchase Eighty-Nine Thousand Seventy Four (89,074) shares of fully paid and nonassessable Common Stock of Cytori Therapeutics Inc., a Delaware corporation (the “Company”), at the Warrant Price (as hereinafter defined), subject to the provisions and upon the terms and conditions hereinafter set forth. As used herein, the term “Common Stock” shall mean Company’s presently authorized common stock, $0.001 par value per share, and any stock into which such common stock may hereafter be converted or exchanged and the term “Warrant Shares” shall mean the shares of Common Stock which Holder may acquire pursuant to this Warrant and any other shares of stock into which such shares of Common Stock may hereafter be converted or exchanged.
WARRANT TO PURCHASE 89,074 SHARES OF COMMON STOCKCytori Therapeutics, Inc. • March 6th, 2009 • Surgical & medical instruments & apparatus • New York
THIS CERTIFIES THAT, for value received, GE Capital Equity Investments, Inc. (“Holder”) is entitled to subscribe for and purchase Eighty-Nine Thousand Seventy Four (89,074) shares of fully paid and nonassessable Common Stock of Cytori Therapeutics Inc., a Delaware corporation (the “Company”), at the Warrant Price (as hereinafter defined), subject to the provisions and upon the terms and conditions hereinafter set forth. As used herein, the term “Common Stock” shall mean Company’s presently authorized common stock, $0.001 par value per share, and any stock into which such common stock may hereafter be converted or exchanged and the term “Warrant Shares” shall mean the shares of Common Stock which Holder may acquire pursuant to this Warrant and any other shares of stock into which such shares of Common Stock may hereafter be converted or exchanged.
